Personalis, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Personalis, Inc. (PSNL) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 3.84% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2026-08-04
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2026-06-30 was 3.84%, a 5.65% decline year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2026-03-31 was 3.71%, a 10.60% decline year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-09-30 was 3.70%, a 6.32% increase year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-06-30 was 4.07%, a 6.44% decline year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2025 was 3.70%, a 6.32% increase from fiscal 2024.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2024 was 3.48%, a 0.29% increase from fiscal 2023.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2023 was 3.47%, a 114.20% increase from fiscal 2022.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2022 was 1.62%, a 161.29% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.84% 10-Q · filed 2026-08-04 | 3.71% 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | 3.71% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 3.70% 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 3.70% 10-Q · filed 2025-11-04 | 3.70% 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | 4.07% 10-Q · filed 2026-08-04 | 4.07% 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | 4.15% 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 3.48% 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 3.48% 10-Q · filed 2025-11-04 | 3.48% 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | 4.35% 10-Q · filed 2025-08-05 | 3.88% 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | 3.88% 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | 3.47% 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 3.99% 10-Q · filed 2024-11-06 | 3.47% 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | 3.47% 10-Q · filed 2024-08-07 | 3.47% 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | 1.62% 10-K · filed 2024-02-28 | |||
| 2022-09-30 | 2.84% 10-Q · filed 2023-11-07 | 1.62% 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | 2.82% 10-Q · filed 2023-08-08 | 1.62% 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | 1.62% 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | 0.62% 10-K · filed 2024-02-28 | |||
| 2021-09-30 | 0.86% 10-Q · filed 2022-11-02 | 0.62% 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | 0.94% 10-Q · filed 2022-08-03 | 0.62% 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | 0.62% 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | 0.36% 10-K · filed 2023-02-23 | |||
| 2020-09-30 | 0.37% 10-Q · filed 2021-11-04 | 0.36% 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | 0.36% 10-Q · filed 2021-08-04 | 0.36% 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | 0.58% 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | 1.53% 10-K · filed 2022-02-24 | |||
| 2019-09-30 | 1.53% 10-Q · filed 2020-11-05 | 1.53% 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | 2.31% 10-Q · filed 2020-08-06 | 2.31% 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 2.49% 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | 2.62% 10-K · filed 2021-02-25 | |||
| 2018-09-30 | 2.62% 10-Q · filed 2019-11-13 | 2.62% 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | 2.84% 10-Q · filed 2019-08-13 | 2.84% 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | 1.88% 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |